Front-line doublets in advanced non-small cell lung cancer: The golden age for second line chemotherapy
- PMID: 15946975
- DOI: 10.1093/annonc/mdi231
Front-line doublets in advanced non-small cell lung cancer: The golden age for second line chemotherapy
Comment on
-
Randomized phase III trial comparing cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer.Ann Oncol. 2005 Jul;16(7):1069-75. doi: 10.1093/annonc/mdi216. Epub 2005 Apr 28. Ann Oncol. 2005. PMID: 15860487 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
